Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower
Ozempic, Oprah and apologies: WeightWatchers says there’s no shame in being overweight, or in taking new weight-loss drugs. Source link
Lululemon's Secret Power: Even Mom Can't Make it Uncool
The maker of workout gear built a multigenerational following. Can it last? Source link
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts
Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Forget the Office Gym. Welcome to the Gym Office.
Working out or just working? More gyms are encouraging remote-working members to stay all day and do both. Source link
These Headphones Stay Outside Your Ears—and Can Go for a Swim
These pairs stay put while logging laps, because of tech called bone conduction. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
The Hidden Career Cost of Being Overweight
New moves to outlaw weight discrimination are pushing companies to examine one of the most insidious forms of on-the-job bias. Source link
Noom Picks Veteran Tech Executive as CEO
Geoff Cook would manage the digital-health platform as the company looks to seize on surging interest in weight-loss treatments. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts
Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in
